SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-20-089193
Filing Date
2020-08-03
Accepted
2020-07-31 17:35:33
Documents
60
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm2020517-1_10q.htm 10-Q 587426
2 EXHIBIT 10.1 tm2020517d1_ex10-1.htm EX-10.1 223811
3 EXHIBIT 31.1 tm2020517d1_ex31-1.htm EX-31.1 7716
4 EXHIBIT 31.2 tm2020517d1_ex31-2.htm EX-31.2 8007
5 EXHIBIT 32.1 tm2020517d1_ex32-1.htm EX-32.1 3994
6 EXHIBIT 32.2 tm2020517d1_ex32-2.htm EX-32.2 3899
  Complete submission text file 0001104659-20-089193.txt   4372727

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT cycn-20200630.xml EX-101.INS 882339
8 XBRL TAXONOMY EXTENSION SCHEMA cycn-20200630.xsd EX-101.SCH 43681
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cycn-20200630_cal.xml EX-101.CAL 51539
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cycn-20200630_def.xml EX-101.DEF 130650
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE cycn-20200630_lab.xml EX-101.LAB 393347
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cycn-20200630_pre.xml EX-101.PRE 269396
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 617-621-7722
Cyclerion Therapeutics, Inc. (Filer) CIK: 0001755237 (see all company filings)

IRS No.: 831895370 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38787 | Film No.: 201067074
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences